GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » Cyclically Adjusted Revenue per Share

Sysmex (TSE:6869) Cyclically Adjusted Revenue per Share : 円594.79 (As of Mar. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Sysmex Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sysmex's adjusted revenue per share for the three months ended in Mar. 2025 was 円227.317. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円594.79 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Sysmex's average Cyclically Adjusted Revenue Growth Rate was 11.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Sysmex was 11.80% per year. The lowest was 8.40% per year. And the median was 10.00% per year.

As of today (2025-05-28), Sysmex's current stock price is 円2444.00. Sysmex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was 円594.79. Sysmex's Cyclically Adjusted PS Ratio of today is 4.11.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sysmex was 12.79. The lowest was 4.08. And the median was 7.06.


Sysmex Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Sysmex's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Cyclically Adjusted Revenue per Share Chart

Sysmex Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 385.84 425.57 479.37 533.02 594.79

Sysmex Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 533.02 547.66 562.85 581.83 594.79

Competitive Comparison of Sysmex's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Sysmex's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sysmex's Cyclically Adjusted PS Ratio falls into.


;
;

Sysmex Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sysmex's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=227.317/111.1000*111.1000
=227.317

Current CPI (Mar. 2025) = 111.1000.

Sysmex Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 92.123 98.400 104.013
201509 102.487 98.500 115.597
201512 102.137 98.100 115.672
201603 106.964 97.900 121.386
201606 94.514 98.100 107.039
201609 95.257 98.000 107.990
201612 99.023 98.400 111.803
201703 110.405 98.100 125.036
201706 98.574 98.500 111.183
201709 110.814 98.800 124.610
201712 114.317 99.400 127.773
201803 125.738 99.200 140.821
201806 105.219 99.200 117.841
201809 112.027 99.900 124.587
201812 115.156 99.700 128.323
201903 135.817 99.700 151.347
201906 109.337 99.800 121.717
201909 118.762 100.100 131.813
201912 119.899 100.500 132.545
202003 133.683 100.300 148.078
202006 96.466 99.900 107.281
202009 114.097 99.900 126.889
202012 127.033 99.300 142.129
202103 148.307 99.900 164.934
202106 126.335 99.500 141.064
202109 142.227 100.100 157.856
202112 143.414 100.100 159.174
202203 166.925 101.100 183.436
202206 137.006 101.800 149.522
202209 171.968 103.100 185.312
202212 166.771 104.100 177.985
202303 178.036 104.400 189.462
202306 151.778 105.200 160.290
202309 186.827 106.200 195.447
202312 181.874 106.800 189.197
202403 215.480 107.200 223.319
202406 179.523 108.200 184.335
202409 209.339 108.900 213.568
202412 199.445 110.700 200.166
202503 227.317 111.100 227.317

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Sysmex  (TSE:6869) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sysmex's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2444.00/594.79
=4.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sysmex was 12.79. The lowest was 4.08. And the median was 7.06.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sysmex Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Sysmex's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex Business Description

Industry
Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex Headlines

No Headlines